Results 231 to 240 of about 483,002 (343)
Evaluation of putrescine's effects on the growth, visual quality, and some physio-biochemical parameters of Henna (Lawsonia inermis L.) under salinity stress conditions. [PDF]
Hamidi Moghaddam A, Sorkhoeih MK.
europepmc +1 more source
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation
METTL5 reshapes the tumor immune microenvironment through ribosome 18S rRNA m6A modification to regulate the translation of chemokine mRNA. Targeting METTL5‐mediated immunosuppression unleashes anti‐tumor immunity and improves the efficacy of anti‐PD‐1 therapy.
Shuang Li +19 more
wiley +1 more source
Analysis of farmers' willingness and concerns of participating in carbon sink loans: evidence from China. [PDF]
Zhu Z, Wang Y, Shao J, Han C, Peng W.
europepmc +1 more source
Quantitative Selection of Long-Short Hedge Funds
Kevin Chen, Alexander Passow
openalex +1 more source
Tumor evolution in lung adenocarcinoma is shaped by genetic alterations and spatial immune dynamics. By integrating whole‐exome sequencing, imaging mass cytometry, and spatial transcriptomics across two mouse models, this study reveals how mutational burden, immune infiltration, and cell–state interactions evolve during early and late carcinogenesis ...
Bo Zhu +34 more
wiley +1 more source
Miyake Revisited: Validating the Factor Structure of an Open-Source Cognitive Control Test Battery. [PDF]
Demeyer F +6 more
europepmc +1 more source
An Empirical Investigation of the VaR of Hedge Funds
Jérôme Teïletche, Florent Pochon
openalex +1 more source
Reviewing the hedge funds literature II: Hedge funds' returns and risk management characteristics
Izidin El Kalak +2 more
semanticscholar +1 more source
PBRM1 ranks as the second most commonly mutated gene in ccRCC. This study reveals that PBRM1 loss promotes an immunosuppressive microenvironment by elevating M2 TAMs via the KDM5C–IL‐6 axis. These M2 TAMs, along with CAFs, form a barrier that excludes CD8+ T cells. Targeting IL‐6 synergizes with anti‐PD1 therapy, offering a promising strategy for PBRM1‐
Wenjiao Xia +14 more
wiley +1 more source

